Top Markets
#1 TENDIES TENDIES +41.21%
#2 Threshold Network Threshold Network +38.17%
#3 Cash Cat Cash Cat +15.80%
#4 OSK OSK +15.39%
#5 Magma Finance Magma Finance +13.81%
#6 Ape and Pepe Ape and Pepe +10.68%
#7 龙虾 (Lobster) 龙虾 (Lobster) +10.47%
#8 Asteroid Shiba Asteroid Shiba +10.17%
#9 Falcon Finance Falcon Finance +10.11%
#10 Safe Safe +8.37%
Coin of the day
TENDIES TENDIES
Settings
Language
ENGLISH
Currency
USD
Theme
Fischer Medical Ventures Ltd. Fischer Medical Ventures Ltd.

Fischer Medical Ventures Ltd.

FISCHER
Rank in Stocks #16812
Fischer Medical Ventures Limited, established in 1993 and headquartered in... Fischer Medical Ventures Limited, established in 1993 and headquartered in Chennai, India, is a global provider of medical equipment. The company's operations encompass the manufacturing, distribution, leasing, and maintenance of a wide array of medical devices. Its comprehensive product offerings include advanced diagnostic imaging systems such as MRI and CT scanners; specialized screening tools for cancer and tuberculosis, including handheld x-ray units; and innovative solutions like spincare technology and contactless screening. The portfolio further extends to preventive health kiosks, e-health access points, various software solutions, plant-derived nutraceuticals, mental health solutions, and a range of other preventive diagnostic devices and ancillary medical instruments. The company adopted its current name, Fischer Medical Ventures Limited, in March 2024, having previously operated as Fischer Chemic Limited.
Share Price
$0.41715616
Market Cap
$273.04M
Change (1 day)
2.41%
Change (1 year)
-65.48%
Country
IN
Trade Fischer Medical Ventures Ltd. (FISCHER)

Category

Healthcare
P/E ratio for Fischer Medical Ventures Ltd. (FISCHER)
P/E ratio as of 2026 TTM: 0
According to Fischer Medical Ventures Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Fischer Medical Ventures Ltd. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.48 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 33.28 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 19.48 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 52.16 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.